Canada Joins International ALS Project

Jan 18, 2017
Dan Haves

Professor Ekaterina RogaevaProfessor Ekaterina Rogaeva University of Toronto Professor Ekaterina Rogaeva is joining an international team of researchers trying to determine why some people develop ALS. Known as Project MinE, the team helped discover the gene linked to ALS. It includes researchers in 17 nations, and now thanks to support from the ALS Society of Canada (ALS Canada), Canadian researchers have joined the team.

“About half of ALS heritability remains to be explained,” says Rogaeva, a Professor in the Department of Medicine, Neurology Division and researcher at the Tanz Centre for Research in Neurodegenerative Diseases.

In an effort to accelerate the search for a cure, Project MinE plans to map the DNA profiles of 15,000 people with ALS along with a control group of 7,500 people and create a global database of genetic information on the disease. ­With this new data, the hope is that researchers around the world can better target ALS by understanding the genetic mutations that lead to disease.

“Only together can we obtain sufficient power to analyze DNA samples from several thousand cases and controls, so the ongoing whole genome sequencing of each MinE sample is critical,” Rogaeva says.

ALS, or amyotrophic lateral sclerosis, is a neurodegenerative disease that gradually paralyzes the body. Most people who are diagnosed with ALS die within two to five years of diagnosis as there is currently no effective treatment or cure. One thousand Canadians are diagnosed with ALS each year.  

Project MinE will receive both the financial support of the ALS Canada and the scientific support of some of Canada’s leading ALS researchers. This is the first cross-Canada collaboration on ALS research and is one of the six projects funded by the ALS Ice Bucket Challenge.

ALS Canada and its research team hope to contribute up to 1,000 DNA profiles to the MinE Project. They are currently seeking federal funding, which would also allow the stored DNA profiles of Canadians with ALS to be added to the database.

“Having such a large sample set could improve understanding of the disease in order to provide the best medical advice to ALS carriers,” Rogaeva notes.



Temerty Medicine
RT : Have you listened to Ep 82 Making Strides: Amputation & Prosthetics yet? 🎧 Aristotle Domingo () shared his…
Temerty Medicine
RT : To avoid a 'twindemic' health officials are telling Canadians to following guidelines for the pandemic, and to get…
Temerty Medicine
“If we can't learn from it then it has little to no scientific value.” Scientists are challenging their colleagues…

Researchers are mobilizing against the novel SARS-CoV-2 coronavirus and COVID-19.

Make a gift and support their important work.
Sep 23 – Nov 11
Safer Opioid Prescribing
Course | 7:00am–9:00pm
Oct 5 – May 6
Academic Health Leadership Training – Now Accepting Applications 2020-2021 Cohort
Course | 8:00am–5:00pm
Oct 13 – Jun 8
Certificate Program in CPD Foundations
Course | 12:00pm–1:30pm
Oct 21 Creating AODA-Compliant Documents for the Web
Webinar | 10:30am–12:00pm
Oct 22 Medicine and the Machine: The Artificial Intelligence Health Revolution
Temerty Medicine Talk | 12:30pm–1:15pm
Oct 23 U of T Oncology Continuing Education Zoom Rounds - October 2020
Grand Rounds | 8:00am–9:00am
24 – 26
Organ Imaging Review
Symposium | 7:15am–5:15pm